Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

Balancing Quality of Life and Life Itself.

Epstein AE.

JACC Clin Electrophysiol. 2019 Jul;5(7):851-853. doi: 10.1016/j.jacep.2019.05.008. No abstract available.

PMID:
31320014
2.

Electrocardiographic and Electrophysiologic Characteristics of Idiopathic Ventricular Arrhythmias Originating From the Basal Inferoseptal Left Ventricle.

Liang JJ, Shirai Y, Briceño DF, Muser D, Enriquez A, Lin A, Hyman MC, Kumareswaran R, Arkles JS, Santangeli P, Schaller RD, Supple GE, Frankel DS, Deo R, Epstein AE, Garcia FC, Riley MP, Nazarian S, Lin D, Callans DJ, Marchlinski FE, Dixit S.

JACC Clin Electrophysiol. 2019 Jul;5(7):833-842. doi: 10.1016/j.jacep.2019.04.002. Epub 2019 May 8.

PMID:
31320012
3.

Noninvasive Programmed Ventricular Stimulation-Guided Management Following Ventricular Tachycardia Ablation.

Muser D, Hayashi T, Castro SA, Supple GE, Schaller RD, Santangeli P, Arkles J, Kumareswaran R, Nazarian S, Deo R, Lin D, Dixit S, Epstein AE, Callans DJ, Marchlinski FE, Frankel DS.

JACC Clin Electrophysiol. 2019 Jun;5(6):719-727. doi: 10.1016/j.jacep.2019.03.007. Epub 2019 May 1.

PMID:
31221360
4.

Leadless Pacemakers and the Tricuspid Valve.

Arkles JS, Epstein AE.

Circ Arrhythm Electrophysiol. 2019 May;12(5):e007375. doi: 10.1161/CIRCEP.119.007375. No abstract available.

PMID:
31060372
5.

Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial.

Healey JS, Gladstone DJ, Swaminathan B, Eckstein J, Mundl H, Epstein AE, Haeusler KG, Mikulik R, Kasner SE, Toni D, Arauz A, Ntaios G, Hankey GJ, Perera K, Pagola J, Shuaib A, Lutsep H, Yang X, Uchiyama S, Endres M, Coutts SB, Karlinski M, Czlonkowska A, Molina CA, Santo G, Berkowitz SD, Hart RG, Connolly SJ.

JAMA Neurol. 2019 Jul 1;76(7):764-773. doi: 10.1001/jamaneurol.2019.0617.

PMID:
30958508
6.

Long-term outcome and mode of recurrence following noninducibility during noninvasive programmed stimulation after ventricular tachycardia ablation.

Shirai Y, Liang JJ, Santangeli P, Arkles JS, Schaller RD, Supple GE, Lin D, Nazarian S, Deo R, Dixit S, Epstein AE, Callans DJ, Marchlinski FE, Frankel DS.

Pacing Clin Electrophysiol. 2019 Mar;42(3):333-340. doi: 10.1111/pace.13605. Epub 2019 Jan 31.

PMID:
30656717
7.

Feasibility of complex transfemoral electrophysiology procedures in patients with inferior vena cava filters.

Mendelson TB, Santangeli P, Frankel DS, Arkles JS, Supple GE, Lin D, Riley MP, Callans DJ, Nazarian S, Hyman MC, Kumareswaran R, Epstein AE, Deo R, Dixit S, Garcia FC, Zado ES, Hutchinson MD, Sadek MM, Cooper JM, Marchlinski FE, Trerotola SO, Schaller RD.

Heart Rhythm. 2019 Jun;16(6):873-878. doi: 10.1016/j.hrthm.2018.12.022. Epub 2018 Dec 24.

PMID:
30590192
8.

A Nurse-Led Limited Risk Factor Modification Program to Address Obesity and Obstructive Sleep Apnea in Atrial Fibrillation Patients.

Yaeger A, Cash NR, Parham T, Frankel DS, Deo R, Schaller RD, Santangeli P, Nazarian S, Supple GE, Arkles J, Riley MP, Garcia FC, Lin D, Epstein AE, Callans DJ, Marchlinski FE, Kolansky DM, Mora JI, Amaro A, Schwab R, Pack A, Dixit S.

J Am Heart Assoc. 2018 Dec 4;7(23):e010414. doi: 10.1161/JAHA.118.010414.

9.

Phosphorylation of Arp2 is not essential for Arp2/3 complex activity in fission yeast.

Epstein AE, Espinoza-Sanchez S, Pollard TD.

Life Sci Alliance. 2018 Oct 29;1(5):e201800202. doi: 10.26508/lsa.201800202. eCollection 2018 Oct.

10.

Long-Term Outcome of Catheter Ablation for Treatment of Bundle Branch Re-Entrant Tachycardia.

Pathak RK, Fahed J, Santangeli P, Hyman MC, Liang JJ, Kubala M, Hayashi T, Muser D, Pathak M, Kochar A, Castro SA, Garcia FC, Frankel DS, Supple GE, Schaller RD, Lin D, Riley MP, Deo R, Epstein AE, Zado ES, Dixit S, Callans DJ, Marchlinski FE.

JACC Clin Electrophysiol. 2018 Mar;4(3):331-338. doi: 10.1016/j.jacep.2017.11.021. Epub 2018 Mar 19.

11.

Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator.

Frankel DS, Burke MC, Callans DJ, Stivland TM, Duffy E, Epstein AE.

JACC Clin Electrophysiol. 2018 May;4(5):652-659. doi: 10.1016/j.jacep.2017.11.019. Epub 2018 Feb 2.

12.

Amiodarone Discontinuation or Dose Reduction Following Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease.

Liang JJ, Yang W, Santangeli P, Schaller RD, Supple GE, Hutchinson MD, Garcia F, Lin D, Dixit S, Epstein AE, Callans DJ, Marchlinski FE, Frankel DS.

JACC Clin Electrophysiol. 2017 May;3(5):503-511. doi: 10.1016/j.jacep.2016.11.005. Epub 2017 Feb 1.

13.

Reversal of Pacing-Induced Cardiomyopathy Following Cardiac Resynchronization Therapy.

Khurshid S, Obeng-Gyimah E, Supple GE, Schaller R, Lin D, Owens AT, Epstein AE, Dixit S, Marchlinski FE, Frankel DS.

JACC Clin Electrophysiol. 2018 Feb;4(2):168-177. doi: 10.1016/j.jacep.2017.10.002. Epub 2017 Nov 15.

14.

Factors Influencing the Decision to Proceed to Firmware Upgrades to Implanted Pacemakers for Cybersecurity Risk Mitigation.

Saxon LA, Varma N, Epstein LM, Ganz LI, Epstein AE.

Circulation. 2018 Sep 18;138(12):1274-1276. doi: 10.1161/CIRCULATIONAHA.118.034781. No abstract available.

PMID:
29748188
15.

Race and stroke in an atrial fibrillation inception cohort: Findings from the Penn Atrial Fibrillation Free study.

Patel PJ, Katz R, Borovskiy Y, Killian A, Levine JM, McNaughton NW, Callans D, Supple G, Dixit S, Epstein AE, Marchlinski FE, Deo R.

Heart Rhythm. 2018 Apr;15(4):487-493. doi: 10.1016/j.hrthm.2017.11.025. Epub 2018 Feb 20.

16.

Class IC antiarrhythmic drugs for suspected premature ventricular contraction-induced cardiomyopathy.

Hyman MC, Mustin D, Supple G, Schaller RD, Santangeli P, Arkles J, Lin D, Muser D, Dixit S, Nazarian S, Epstein AE, Callans DJ, Marchlinski FE, Frankel DS.

Heart Rhythm. 2018 Feb;15(2):159-163. doi: 10.1016/j.hrthm.2017.12.018.

PMID:
29405947
17.

Sudden Cardiac Death: Lessons Learned from Cardiac Implantable Rhythm Devices.

Santangeli P, Epstein AE.

Card Electrophysiol Clin. 2017 Dec;9(4):749-759. doi: 10.1016/j.ccep.2017.08.005. Review.

PMID:
29173415
18.

Automatic remote monitoring utilizing daily transmissions: transmission reliability and implantable cardioverter defibrillator battery longevity in the TRUST trial.

Varma N, Love CJ, Schweikert R, Moll P, Michalski J, Epstein AE; TRUST Investigators.

Europace. 2018 Apr 1;20(4):622-628. doi: 10.1093/europace/eux059.

PMID:
29016878
19.

Exploring the dark side of left atrial appendage closure devices.

Santangeli P, Epstein AE.

J Cardiovasc Electrophysiol. 2018 Jan;29(1):14-16. doi: 10.1111/jce.13358. Epub 2017 Oct 31. No abstract available.

PMID:
28988462
20.

Utility of intracardiac echocardiography during transvenous lead extraction.

Sadek MM, Cooper JM, Frankel DS, Santangeli P, Epstein AE, Marchlinski FE, Schaller RD.

Heart Rhythm. 2017 Dec;14(12):1779-1785. doi: 10.1016/j.hrthm.2017.08.023. Epub 2017 Aug 24.

PMID:
28843419
21.

Association Between Patient-Reported Medication Adherence and Anticoagulation Control.

Sevilla-Cazes J, Finkleman BS, Chen J, Brensinger CM, Epstein AE, Streiff MB, Kimmel SE.

Am J Med. 2017 Sep;130(9):1092-1098.e2. doi: 10.1016/j.amjmed.2017.03.038. Epub 2017 Apr 26.

22.

Predicting prolonged dose titration in patients starting warfarin.

Finkelman BS, French B, Bershaw L, Brensinger CM, Streiff MB, Epstein AE, Kimmel SE.

Pharmacoepidemiol Drug Saf. 2016 Nov;25(11):1228-1235. doi: 10.1002/pds.4069. Epub 2016 Jul 26.

23.

Right Ventricular Pacing-Induced Hemodynamic Compromise in a Patient With a Left Ventricular Assist Device.

Hyman MC, Schaller RD, Epstein AE, Rame JE.

Circ Arrhythm Electrophysiol. 2016 Nov;9(11). pii: e004622. No abstract available.

PMID:
27793957
24.

The wearable cardioverter-defibrillator: current technology and evolving indications.

Reek S, Burri H, Roberts PR, Perings C, Epstein AE, Klein HU; EHRA Scientific Documents Committee (as external reviewers):, Lip G, Gorenek B, Sticherling C, Fauchier L, Goette A, Jung W, Vos MA, Brignole M, Elsner C, Dan GA, Marin F, Boriani G, Lane D, Blomström-Lundqvist C, Savelieva I.

Europace. 2017 Mar 1;19(3):335-345. doi: 10.1093/europace/euw180. Review.

PMID:
27702851
25.

Outcomes in Patients With Congenital Heart Disease Receiving the Subcutaneous Implantable-Cardioverter Defibrillator: Results From a Pooled Analysis From the IDE Study and the EFFORTLESS S-ICD Registry.

D'Souza BA, Epstein AE, Garcia FC, Kim YY, Agarwal SC, Belott PH, Burke MC, Leon AR, Morgan JM, Patton KK, Shah M.

JACC Clin Electrophysiol. 2016 Oct;2(5):615-622. doi: 10.1016/j.jacep.2016.02.008. Epub 2016 May 18.

26.

Longer Paced QRS Duration is Associated With Increased Prevalence of Right Ventricular Pacing-Induced Cardiomyopathy.

Khurshid S, Liang JJ, Owens A, Lin D, Schaller R, Epstein AE, Marchlinski FE, Frankel DS.

J Cardiovasc Electrophysiol. 2016 Oct;27(10):1174-1179. doi: 10.1111/jce.13045. Epub 2016 Aug 19.

PMID:
27457998
27.

Disparities in Prenatal Care Utilization Among U.S. Versus Foreign-Born Women with Chronic Conditions.

Goldfarb SS, Smith W, Epstein AE, Burrows S, Wingate M.

J Immigr Minor Health. 2017 Dec;19(6):1263-1270. doi: 10.1007/s10903-016-0435-x.

PMID:
27221086
28.

Moving Further Upstream in the Prevention of Cardiac Arrest and its Complications.

Deo R, Epstein AE.

J Am Coll Cardiol. 2016 May 3;67(17):1991-3. doi: 10.1016/j.jacc.2016.03.473. No abstract available.

29.

Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials.

Santangeli P, Muser D, Maeda S, Filtz A, Zado ES, Frankel DS, Dixit S, Epstein AE, Callans DJ, Marchlinski FE.

Heart Rhythm. 2016 Jul;13(7):1552-9. doi: 10.1016/j.hrthm.2016.03.004. Epub 2016 Mar 4. Review.

PMID:
26961297
30.

Arrhythmias in advanced heart failure are a bad sign-but of what?

Callans DJ, Epstein AE.

Heart Rhythm. 2016 May;13(5):1057-1058. doi: 10.1016/j.hrthm.2016.02.010. Epub 2016 Feb 23. No abstract available.

PMID:
26924567
31.

The Wearable Cardioverter-Defibrillator in Newly Diagnosed Cardiomyopathy: Treatment on the Basis of Perceived Risk.

Epstein AE.

J Am Coll Cardiol. 2015 Dec 15;66(23):2614-2617. doi: 10.1016/j.jacc.2015.09.078. No abstract available.

32.

Role of Automatic Wireless Remote Monitoring Immediately Following ICD Implant: The Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) Trial.

Varma N, Epstein AE, Schweikert R, Michalski J, Love CJ; TRUST Investigators.

J Cardiovasc Electrophysiol. 2016 Mar;27(3):321-6. doi: 10.1111/jce.12895. Epub 2016 Jan 27.

PMID:
26661687
33.

Complete Heart Block Complicating ST-Segment Elevation Myocardial Infarction Has Not Gone Away.

Epstein AE.

JACC Clin Electrophysiol. 2015 Dec;1(6):539-541. doi: 10.1016/j.jacep.2015.09.005. Epub 2015 Oct 17. No abstract available.

34.

Cardiovascular implantable electronic device lead extraction: evidence, techniques, results, and future directions.

Sadek MM, Goldstein W, Epstein AE, Schaller RD.

Curr Opin Cardiol. 2016 Jan;31(1):23-8. doi: 10.1097/HCO.0000000000000247. Review.

PMID:
26595700
35.

Optimal QT interval correction formula in sinus tachycardia for identifying cardiovascular and mortality risk: Findings from the Penn Atrial Fibrillation Free study.

Patel PJ, Borovskiy Y, Killian A, Verdino RJ, Epstein AE, Callans DJ, Marchlinski FE, Deo R.

Heart Rhythm. 2016 Feb;13(2):527-35. doi: 10.1016/j.hrthm.2015.11.008. Epub 2015 Nov 10.

36.

Practical Management Guide for Clinicians Who Treat Patients with Amiodarone.

Epstein AE, Olshansky B, Naccarelli GV, Kennedy JI Jr, Murphy EJ, Goldschlager N.

Am J Med. 2016 May;129(5):468-75. doi: 10.1016/j.amjmed.2015.08.039. Epub 2015 Nov 11. Review.

PMID:
26497904
37.

Hybrid Ablation in the Arms Race for the Treatment of AF.

Epstein AE, Callans DJ.

Pacing Clin Electrophysiol. 2015 Dec;38(12):1377-8. doi: 10.1111/pace.12700. Epub 2015 Sep 2. No abstract available.

PMID:
26227867
38.

Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival.

Khurshid S, Akerman S, Man JP, Supple G, Dixit S, Epstein AE, Marchlinski FE, Frankel DS.

J Interv Card Electrophysiol. 2015 Mar;42(2):117-24. doi: 10.1007/s10840-015-9974-7. Epub 2015 Jan 27.

PMID:
25620152
39.

Reflections on the lowly PVC.

Callans DJ, Epstein AE.

Heart Rhythm. 2015 Apr;12(4):714-5. doi: 10.1016/j.hrthm.2014.12.030. Epub 2014 Dec 26. No abstract available.

PMID:
25546808
40.

Pseudo-tamponade during transvenous lead extraction.

Sadek MM, Epstein AE, Cheung AT, Schaller RD.

Heart Rhythm. 2015 Apr;12(4):849-50. doi: 10.1016/j.hrthm.2014.12.016. Epub 2014 Dec 19. No abstract available.

PMID:
25533583
41.

Pneumatic retinopexy for retinal detachment occurring after prior scleral buckle or pars plana vitrectomy.

Modi YS, Townsend J, Epstein AE, Smiddy WE, Flynn HW Jr.

Ophthalmic Surg Lasers Imaging Retina. 2014 Sep-Oct;45(5):409-13. doi: 10.3928/23258160-20140909-05.

PMID:
25291784
42.

Prospective long-term evaluation of Optim-insulated (Riata ST Optim and Durata) implantable cardioverter-defibrillator leads.

Cairns JA, Epstein AE, Rickard J, Connolly SJ, Buller C, Wilkoff BL, Pogue J, Themeles E, Healey JS.

Heart Rhythm. 2014 Dec;11(12):2156-62. doi: 10.1016/j.hrthm.2014.08.023. Epub 2014 Aug 15.

PMID:
25131665
43.

Incidence and predictors of right ventricular pacing-induced cardiomyopathy.

Khurshid S, Epstein AE, Verdino RJ, Lin D, Goldberg LR, Marchlinski FE, Frankel DS.

Heart Rhythm. 2014 Sep;11(9):1619-25. doi: 10.1016/j.hrthm.2014.05.040. Epub 2014 Jun 2.

PMID:
24893122
44.

Influence of healthy candidate bias in assessing clinical effectiveness for implantable cardioverter-defibrillators: cohort study of older patients with heart failure.

Setoguchi S, Warner Stevenson L, Stewart GC, Bhatt DL, Epstein AE, Desai M, Williams LA, Chen CY.

BMJ. 2014 May 8;348:g2866. doi: 10.1136/bmj.g2866.

45.

Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met?

Kini V, Soufi MK, Deo R, Epstein AE, Bala R, Riley M, Groeneveld PW, Shalaby A, Dixit S.

J Am Coll Cardiol. 2014 Jun 10;63(22):2388-94. doi: 10.1016/j.jacc.2014.03.025. Epub 2014 Apr 9.

46.

Utilizing optical coherence tomography in diagnosing a unique presentation of chiasmal hypoplasia variant of septo-optic dysplasia.

Epstein AE, Cavuoto KM, Chang TC.

J Neuroophthalmol. 2014 Mar;34(1):103-4. doi: 10.1097/WNO.0000000000000092. No abstract available.

PMID:
24451551
47.

Unipolar voltage abnormality is associated with greater left ventricular dysfunction in ischemic cardiomyopathy.

Aldhoon B, Frankel DS, Hutchinson MD, Callans DJ, Epstein AE, Dixit S, Riley MP, Lin D, Garcia FC, Supple GE, Cooper JM, Bala R, Deo R, Zado ES, Marchlinski FE.

J Cardiovasc Electrophysiol. 2014 Mar;25(3):293-8. doi: 10.1111/jce.12315. Epub 2013 Dec 4.

PMID:
24237590
48.

Inducible fast ventricular tachycardia after ST-segment--elevation myocardial infarction: is ventricular tachycardia ever OK?

Epstein AE, Callans DJ.

Circ Arrhythm Electrophysiol. 2013 Oct;6(5):830-2. doi: 10.1161/CIRCEP.113.000938. No abstract available.

PMID:
24129203
49.

Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation.

Shariff N, Desai RV, Patel K, Ahmed MI, Fonarow GC, Rich MW, Aban IB, Banach M, Love TE, White M, Aronow WS, Epstein AE, Ahmed A.

Am J Med. 2013 Oct;126(10):887-93. doi: 10.1016/j.amjmed.2013.04.021.

50.

The disconnect between the guidelines, the appropriate use criteria, and reimbursement coverage decisions: the ultimate dilemma.

Fogel RI, Epstein AE, Mark Estes NA 3rd, Lindsay BD, DiMarco JP, Kremers MS, Kapa S, Brindis RG, Russo AM.

J Am Coll Cardiol. 2014 Jan 7-14;63(1):12-4. doi: 10.1016/j.jacc.2013.07.016. Epub 2013 Jul 31. Review.

Supplemental Content

Loading ...
Support Center